scholarly article | Q13442814 |
P50 | author | Detlef Schuppan | Q17418245 |
P2093 | author name string | Masahiko Shimada | |
Shuhei Yoshida | |||
Ryota Masuzaki | |||
P433 | issue | 1 | |
P921 | main subject | ribavirin | Q421862 |
pegylated interferon | Q7160835 | ||
chronic hepatitis C | Q55779873 | ||
P304 | page(s) | 299-300 | |
P577 | publication date | 2011-06-28 | |
P1433 | published in | Journal of Hepatology | Q15724402 |
P1476 | title | Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: a prospective randomized pilot study. | |
P478 | volume | 56 |
Q50550427 | Add-on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C. |
Q38198618 | Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality |
Q55280981 | Host-targeting therapies for hepatitis C virus infection: current developments and future applications. |
Q50549620 | Meloxicam as an adjuvant to peginterferon-α-2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial. |
Q36026554 | Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments |
Q37182990 | Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents |